Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
PharmacoEconomics
Published in: PharmacoEconomics 8/2006

01-08-2006 | Correspondence

National-Level Purchasing of Expensive Drugs is Increasing Pressure on the Hospital Drug Budget

Authors: Slobodan M. Jankovic, Nebojsa Milivojevic

Published in: PharmacoEconomics | Issue 8/2006

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Seoane Vázquez EC, Rodríguez-Monguió R. Analisis del Impacta de la Negociacion de Precios de Medicamentos y Reactivos para el VIHlSIDA en los Paises Andinos. Report for Organizacion Pan Americana de la Salud [online]. Available from URL: http://​www.​paho.​org/​Spanish/​AD/​FCH/​AI/​NegociacionPreci​osVIH.​pdf [Accessed 2006 Jul 3]
2.
Decision on standards for administration of cytostatics which are not on the list of drugs. Belgrade: Managing Board of Republic Institute for Health Insurance, 2004 Apr. Report no.: 54-333/04
3.
Decision on list of drugs which are prescribed and dispensed on account of health insurance. Official Gazette of Republic of Serbia 2005; 61 (6): 1-111
4.
Instructions for prescribing and dispensing drugs with special dispensing regime. Belgrade: Republic Institute for Health Insurance, 2005
5.
Decision on standards for administration of cytostatics and other specific drugs for treatment of malignant diseases, which are on the list of drugs. Belgrade: Managing Board of Republic Institute for Health Insurance, 2005. Nurmer 54-279/05
6.
Stokoe H, Samways D. Purchasing medicines. In: Stephens M, editor. Hospital pharmacy. 1st ed. London: Pharmaceutical Press, 2003: 17–28
Metadata
Title
National-Level Purchasing of Expensive Drugs is Increasing Pressure on the Hospital Drug Budget
Authors
Slobodan M. Jankovic
Nebojsa Milivojevic
Publication date
01-08-2006
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue 8/2006
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200624080-00008

Other articles of this Issue 8/2006

PharmacoEconomics 8/2006 Go to the issue

Original Research Article

Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada

Original Research Article

Pharmacoeconomic Analyses of Azathioprine, Methotrexate and Prospective Pharmacogenetic Testing for the Management of Inflammatory Bowel Disease

Review Article

Prostaglandin Analogues for the Treatment of Glaucoma and Ocular Hypertension

Review Article

A Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials

Review Article

Cost Effectiveness of Leukotriene Modifiers in Adults with Asthma

Original Research Article

A Multi-Country Health Economic Evaluation of Highly Concentrated N-3 Polyunsaturated Fatty Acids in Secondary Prevention after Myocardial Infarction